Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell … – Business Wire (press release)
|
Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell …
Business Wire (press release) NEW YORK–(BUSINESS WIRE)–Angiocrine Bioscience, Inc. announced today that it has licensed the rights to a new technology developed by a team of researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College. The team was led by Dr. |
